Enoxaparin-Induced Liver Injury.
Drug-induced liver injury
Enoxaparin
Non-alcoholic fatty liver disease
Viral hepatitis
Journal
Case reports in gastroenterology
ISSN: 1662-0631
Titre abrégé: Case Rep Gastroenterol
Pays: Switzerland
ID NLM: 101474819
Informations de publication
Date de publication:
Historique:
received:
08
04
2020
accepted:
01
05
2020
entrez:
30
6
2020
pubmed:
1
7
2020
medline:
1
7
2020
Statut:
epublish
Résumé
Enoxaparin, a form of low-molecular-weight heparin, can cause a rare, underreported, and often reversible form of hepatocellular injury. This report describes a case of enoxaparin-induced hepatotoxicity in a 61-year-old male diagnosed with pulmonary embolism. Elevations of liver enzymes were noted within 1 week of starting the drug, followed by a dramatic improvement upon its discontinuation, with subsequent normalization in the following days.
Identifiants
pubmed: 32595436
doi: 10.1159/000508471
pii: crg-0014-0315
pmc: PMC7315174
doi:
Types de publication
Case Reports
Langues
eng
Pagination
315-319Informations de copyright
Copyright © 2020 by S. Karger AG, Basel.
Déclaration de conflit d'intérêts
The authors declare that they have no conflicts of interest to disclose.
Références
Circulation. 2006 Apr 18;113(15):e698-702
pubmed: 16618822
Clin Pharmacol Ther. 1981 Aug;30(2):239-45
pubmed: 7249508
Am J Health Syst Pharm. 2009 Apr 1;66(7):638-41
pubmed: 19299370
Pharmacotherapy. 2001 Jan;21(1):108-13
pubmed: 11191729
Drug Saf Case Rep. 2015 Dec;2(1):17
pubmed: 27747729
Int J Mol Sci. 2015 Dec 24;17(1):
pubmed: 26712744
J Clin Pharmacol. 2001 Jun;41(6):691-4
pubmed: 11402639
Drug Saf. 2018 Aug;41(8):735-743
pubmed: 29502198
Blood. 1992 Jan 1;79(1):1-17
pubmed: 1309422
Ann Intern Med. 1984 May;100(5):646-50
pubmed: 6712030